In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.
During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal salt form and appropriate excipients to achieve the desired release profile. These steps are crucial for creating a high-quality, reliable drug product that meets therapeutic objectives.
Dissolution testing continues to play a key role beyond formulation. It monitors product stability over time and evaluates the impact of manufacturing processes. Scientists can confirm that the product maintains its intended performance by analyzing how the drug dissolves throughout its shelf life. This makes dissolution testing a valuable stability-indicating tool.
In quality control, these tests ensure batch-to-batch reproducibility. Variations in drug release may indicate changes in raw materials or manufacturing conditions. A well-designed dissolution method can detect such variations, ensuring only products meeting release criteria reach patients. Importantly, these methods must be specific to the drug and its formulation to differentiate between acceptable and unacceptable versions under identical test conditions.
Any minor formulation or process change for marketed products requires regulatory review. Under the Scale-Up and Post-Approval Changes (SUPAC) guidelines, manufacturers must demonstrate that the new product maintains similar bioavailability by comparing its dissolution profile to the original. This comparison helps assess whether changes affect the drug’s in vivo behavior and supports continued product approval.
Overall, in vitro dissolution testing is fundamental to drug development, ensuring safety, efficacy, and quality throughout a product’s life cycle.
In vitro dissolution and drug release tests evaluate the rate and extent of the drug released from a product in an aqueous medium under defined conditions.
During formulation development, dissolution testing uncovers formulation defects and helps in salt form and excipient selection, ensuring a quality finished product.
These tests monitor drug product stability and the manufacturing process, confirming the product's consistent performance throughout its shelf life.
Additionally, they serve as a quality control measure by validating batch-to-batch reproducibility and detecting variations in composition and manufacturing.
Notably, a dissolution method tailored to the specific drug product and its formulation identifies acceptable and unacceptable drug formulations under the same testing conditions.
In marketed products, the impact of minor formulation modifications on the drug’s bioavailability is assessed by comparing pre- and post-change product dissolution profiles.
繁體中文
